Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pemafibrate/Tofogliflozin - Kowa

Next Previous
X
Search
Drug Profile

Pemafibrate/Tofogliflozin - Kowa

Alternative Names: K-001 - Kowa; K001; Tofogliflozin/Pemafibrate - Kowa

Latest Information Update: 20 Apr 2023

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Kowa
  • Class Antihyperglycaemics; Antihyperlipidaemics; Benzhydryl compounds; Benzofurans; Benzoxazoles; Butyric acids; Cardiovascular therapies; Fibric acid derivatives; Glucosides; Small molecules; Spiro compounds; Vascular disorder therapies
  • Mechanism of Action Peroxisome proliferator-activated receptor alpha agonists; Sodium-glucose transporter 2 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Non-alcoholic steatohepatitis

Most Recent Events

  • 24 Feb 2023 Kowa Research Institute initiates a phase I trial in Healthy volunteers in the US (PO, Tablet) (NCT05722262)
  • 14 Oct 2022 Phase-II clinical trials in Non-alcoholic steatohepatitis in Japan before October 2022 (unspecified route) (Kowa Pharmaceutical pipeline, October 2022)
  • 31 Dec 2021 Phase-I clinical trials in nonalcoholic steatohepatitis in Japan (unspecified route) (Kowa pipeline, December 2021)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top